Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Bone Diseases × Estrogen Replacement Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1 Breast 1

Conditions

Osteoporosis 1 Myocardial Ischemia 1 Heart Diseases 1 Coronary Disease 1 Colonic Neoplasms 1 Cardiovascular Diseases 1 Breast Neoplasms 1 Bone Diseases 1

Interventions

Denosumab 2 Zoledronic Acid 1 Vitamin D 1 Progestins 1 Hormone Replacement Therapy 1 Estrogens 1 Estrogen Replacement Therapy 1 Dietary Supplements 1 Diet, Fat-Restricted 1 Calcium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00000611 2016-04-15

Women's Health Initiative (WHI)

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed

BreastGastrointestinal

Bone Diseases, Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Coronary Disease, Heart Diseases, Osteoporosis, Myocardial Ischemia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡